Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases

Publisher Website
Google Scholar
Abstract
The total serum sialic acid concentration was determined in 2,264 persons with various malignant tumors, bacterial infections, rheumatic diseases, and chronic liver diseases, and in a control group. The thiobarbiturate method according to Warren was used [34]. The upper limit (95% percentile) in the control group was 2.23 μmol/ml. Higher values were found in the groups with neoplasms (mean: 3.04 μmol/ml), inflammatory diseases (e.g., pneumonia: 3.02 μmol/ml), and active rheumatoid arthritis (3.05 μmol/ml). In the group with malignant diseases, the sialic acid concentration at the time of diagnosis was highest for bronchial carcinoma (3.29 μmol/ml) and lowest for breast cancer (2.58 μmol/ml). In chronic liver diseases the mean sialic acid level was lower than in a heterogeneous group of noninflammatory and nonneoplastic diseases. The estimation of the serum sialic acid concentration could be useful in the detection of tumor burden and metastases, and in the evaluation of the later course and prognosis of malignant neoplasms if bacterial/inflammatory and active rheumatoid processes can be excluded.

This publication has 39 references indexed in Scilit: